Argpyrimidine-tagged rutin-encapsulated biocompatible (ethylene glycol dimers) nanoparticles: Synthesis, characterization and evaluation for targeted drug delivery

International Journal of Pharmaceutics

Volumn 509, Issue 1-2, 2016, Pages 507-517

  Bhattacherjee, Abhishek ^a,b   Dhara, Kaliprasanna ^a   Chakraborti, Abhay Sankar ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Advanced glycation end product; Argpyrimidine; Diabetes mellitus; Drug delivery; Nanotechnology; Rutin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; ANTIOXIDANT; ARGPYRIMIDINE; ETHYLENE GLYCOL BIS(SUCCINIC ACID HYDROXYSUCCINIMIDE ESTER); ETHYLENE GLYCOL DERIVATIVE; NANOPARTICLE; PYRIMIDINE DERIVATIVE; RUTOSIDE; UNCLASSIFIED DRUG; BIOMATERIAL; ETHYLENE GLYCOL; N-HYDROXYSUCCINIMIDE; ORNITHINE; POLYMER; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFUSION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; EX VIVO STUDY; HYDRODYNAMICS; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; LIVER CELL; MALE; MAXIMUM PLASMA CONCENTRATION; MOLECULAR DOCKING; MOLECULAR WEIGHT; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TIMED DRUG RELEASE; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CHEMISTRY; DIABETES MELLITUS; PROCEDURES; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; ETHYLENE GLYCOL; MALE; NANOPARTICLES; ORNITHINE; POLYMERS; PYRIMIDINES; RATS; RATS, WISTAR; RUTIN; SUCCINIMIDES;

EID: 84973514380     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.05.042     Document Type: Article

References (46)

1. Arayne, M.S., Sultana, N., Qureshi, F., Nanoparticles in delivery of cardiovascular drugs. Pak. J. Pharm. Sci. 20 (2007), 340–348.
2. Bae, Y., Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug. Chem. 16 (2004), 122–130.
3. Banfi, D., Patiny, L., Resurrecting and processing NMR spectra on-line. Chimia 62 (2008), 280–281.
4. Basta, G., Schmidt, A.M., de Caterinaa, R., Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardio. Res. 63 (2004), 582–592.
5. 2+) form. Int. J. Biol. Macromol. 48 (2011), 202–209.
6. Bhattacherjee, A., Chakraborti, A.S., Inhibitory effect of Piper betle Linn. leaf extract on protein glycation—quantification and characterization of the antiglycation components. Ind. J. Biochem. Biophys. 50 (2013), 529–536.
7. Bokkenheuser, V.D., Shackleton, C.H., Winter, J., Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteriodes from humans. Biochem. J. 248 (1987), 953–956.
8. Boyle, S.P., Dobson, V.L., Duthie, S.J., Hinselwood, D.C., Kyle, J.A., Collins, A.R., Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. Eur. J. Clin. Nutr. 54 (2000), 774–782.
9. Cheng, J., Teply, B.A., Sherifi, I., Sung, J., Luther, G., Gu, F.X., Levy-Nissenbaum, E., Radovic-Moreno, A.F., Langer, R., Farokhzad, O.C., Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28 (2007), 869–876.
10. Davis, M.E., Chen, Z.G., Shin, D.M., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008), 771–782.
11. Erlundet, I., Kosonen, T., Alfthan, G., Mäenpää, J., Perttunen, K., Kenraali, J., Parantainen, J., Aro, A., Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56 (2000), 545–553.
12. Fiege, B., Ballhausen, D., Kierat, L., Leimbacher, W., Goriounov, D., Schircks, B., Theony, B., Blau, N., Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol. Gen. Metabol. 81 (2004), 45–51.
13. Gaiser, B.K., Hirn, S., Kermanizadeh, A., Kanase, N., Fytianos, K., Wenk, A., Haberl, N., Brunelli, A., Kreyling, W.G., Stone, V., Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol. Sci. 131 (2013), 537–547.
14. Gao, Z., Xu, H., Huang, K., Effects of rutin supplementation on antioxidant status and iron,copper, and zinc contents in mouse liver and brain. Biol. Trace Elem. Res. 88 (2002), 271–279.
15. Gomes, R., Silva, M.S., Quintas, A., Cordeiro, C., Freire, A., Pereira, P., Martins, A., Monteiro, E., Barroso, E., Freire, A.P., Argpyrimidine, a methylglyoxal-derived advanced glycationend-product in familial amyloidotic polyneuropathy. Biochem. J. 385 (2005), 339–345.
16. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., Langer, R., Biodegradable long-circulating polymeric nanospheres. Science 263 (1994), 1600–1603.
17. Gu, F., Zhang, L., Teply, B.A., Mann, N., Wang, A., Radovic-Moreno, A.F., Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. 105 (2008), 2586–2591.
18. Jadhav, R., Puchchakayala, G., Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats. Int. J. Pharm. Pharm. Sci. 4 (2012), 251–256.
19. Jawahar, N., Venkatesh, D.N., Sureshkumar, R., Senthil, V., Ganesh, G.N.K., Vinoth, P., Sood, S., Samanta, M.K., Development and charecterization of PLGA-nanoparticles containing carvedilol. J. Pharm. Sci. Res. 1 (2009), 123–128.
20. Lee, A., Yang, H.J., Kim, Y., Kim, J., Effect of dihydroxybenzoic acid isomers on the analysis of polyethylene glycols in MALDI-MS. Bull. Korean Chem. Soc. 30 (2009), 1127–1130.
21. Levchenko, L.A., Golovanova, S.A., Lariontseva, N.V., Sadkov, A.P., YumVoilov, D., Nikitenko, N.G., Shestakov, A.F., Synthesis and study of gold nanoparticles stabilized by bioflavonoids. Rus. Chem. Bull. 60 (2011), 426–433.
22. Li, Y.J., Sui, Y.J., Dai, Y.H., Deng, Y.L., Determination and pharmacokinetics study of mangiferin in rat plasma and tissues. Chromatographia 67 (2008), 957–960.
23. Lianga, C.C., Honga, C.Y., Chenb, C.F., Tsaib, T.H., Measurement and pharmacokinetic study of tetramethylpyrazine in rat blood and its regional brain tissue by high-performance liquid chromatography. J. Chromatogr. B 724 (1999), 303–309.
24. Louis, J.S., Denise, A.A., Rui, K., Daolin, T., Neilay, A., Jaehyun, I., Ronnye, R., RAGE (receptor for advanced glycation endproducts) RAGE ligands, and their role in cancer and inflammation. J. Trans. Med., 7, 2009, 17.
25. Lukyanov, A.N., Elbayoumi, T.A., Chakilam, A.R., Torchilin, V.P., Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Control. Release 100 (2004), 135–144.
26. Marchetti, P., Advanced glycation end products (AGEs) and their receptors (RAGEs) indiabetic vascular disease. Medicographia 31 (2009), 257–265.
27. McCarthy, A.D., Etcheverry, S.B., Cortizo, A.M., Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation. Acta Diabetol. 36 (1999), 45–52.
28. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., Olson, A.J., Automatic docking using a Lamarckian genetic alogarithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998), 1639–1662.
29. Nakajima, A., et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behav. Brain Res. 289 (2015), 69–77.
30. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F., Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immuno. Meth. 139 (1991), 271–279.
31. Olivier, J.C., Drug transport to brain with targeted nanoparticles. NeuroRx 2 (2005), 108–119.
32. Orive, G., Hernandez, R.M., Rodriguez, G.A., Dominguez-Gil, A., Pedraz, J.L., Drug delivery in biotechnology: present and future. Curr. Opin. Biotechnol. 14 (2003), 659–664.
33. Petros, R.A., Desimone, J.M., Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug. Discov. 9 (2010), 615–627.
34. Reddy, G.B., Muthenna, P., Akileshwari, C., Saraswat, M., Petrash, J.M., Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Curr. Sci. 101 (2011), 191–197.
35. Sanna, V., Pintus, G., Roggio, A.M., Punzoni, S., Posadino, A.M., Arca, A., Marceddu, S., Bandiera, P., Uzzau, S., Sechi, M., Targeted biocompatible nanoparticles for the delivery of (−)-epigallocatechin 3-gallate to prostate cancer cells. J. Med. Chem. 54 (2011), 1321–1332.
36. Sarkar, K., Ghosh, A., Kinter, M., Mazumder, B., Sil, P.C., Purification and characterizationof a 43 kD hepatoprotective protein from the herb Cajanusindicus L. Protein J. 25 (2006), 411–421.
37. Shi, Z., Guo, R., Li, W., Zhang, Y., Xue, W., Tang, Y., Zhang, Y., Nanoparticles of deoxycholic acid: polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin. J. Mater. Sci. Mater. Med. 3 (2013), 723–731.
38. Sreejayan, N., Yang, X., Palanichamy, K., Dolence, K., Ren, J., Antioxidant properties of argpyrimidine. Eu. J. Pharmacol. 593 (2008), 30–35.
39. Torchilin, V.P., Targeted polymeric micelles for delivery of poorly soluble drugs. Cell. Mol. Life Sci. 61 (2004), 2549–2559.
40. Wang, P., Henning, S.M., Heber, D., vadgama, J.V., Sensitization to docetaxel in prostate cancer cells by green tea and quercetin. J. Nutr. Biochem. 26 (2015), 408–415.
41. Wautier, J.L., Guillausseau, P.J., Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes. Metab. 27 (2001), 535–542.
42. Wilker, S.C., Chellan, P., Arnold, B.M., Nagaraj, R.H., Chromatographic quantification of argpyrimidine, a methylglyoxal derived product in tissue protein: comparisons with pentosidine. Anal. Biochem. 290 (2001), 353–358.
43. Wu, C.H., Yen, G.C., Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 53 (2005), 3167–3173.
44. Wu, Y., Yang, W., Wang, C., Hu, J., Fu, S., Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. 295 (2005), 235–245.
45. Yon, J.Y., Bae, Y.J., Kim, E.Y., Lee, E.J., Association between flavonoid intake and diabetes risk among the Koreans. Clin. Chim. Acta 439 (2015), 225–230.
46. Zhang, Y., et al. Antioxidant effects of liquorice (Glycyrrhiza uralensis) extract during aging of longissimus thoracis muscle in Tan sheep. Meat Sci. 105 (2015), 38–45.